The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial.
Chinese journal of traumatology = Zhonghua chuang shang za zhi · 2017-01-20 · Randomised trial
Abstract
PURPOSE: Traumatic brain injury (TBI) is a leading cause of death and disability. Intracranial hemorrhage (ICH) secondary to TBI is associated with a high risk of coagulopathy which leads to increasing risk of hemorrhage growth and higher mortality rate. Therefore, antifibrinolytic agents such as tranexamic acid (TA) might reduce traumatic ICH. The aim of the present study was to investigate the extent of ICH growth after TA administration in TBI patients. METHODS: This single-blind randomized controlled trial was conducted on patients with traumatic ICH (with less than 30 ml) referring to the emergency department of Vali-Asr Hospital, Arak, Iran in 2014. Patients, based on the inclusion and exclusion criteria, were divided into intervention and control groups (40 patients each). All patients received a conservative treatment for ICH, as well as either intravenous TA or placebo. The extent of ICH growth as the primary outcome was measured by brain CT scan after 48 h. RESULTS: Although brain CT scan showed a significant increase in hemorrhage volume in both groups after 48 h, it was significantly less in the TA group than in the control group (p = 0.04). The mean total hemorrhage expansion was (1.7 ± 9.7) ml and (4.3 ± 12.9) ml in TA and placebo groups, respectively (p < 0.001). CONCLUSION: It has been established that TA, as an effective hospital-based treatment for acute TBI, could reduce ICH growth. Larger studies are needed to compare the effectiveness of different doses.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Haemostatics · Tranexamic acid
Related articles
- Prehospital Pharmacotherapy in Moderate and Severe Traumatic Brain Injury: A Systematic Review. (Med J (Ft Sam Houst Tex), 2023)
- Association between coagulation biomarkers, intracranial hemorrhage types, and tranexamic acid treatments in early traumatic brain injury. (J Trauma Acute Care Surg, 2025)
- Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI). (Transfus Med Rev, 2021)
- Enrollment with and without exception from informed consent in a pilot trial of tranexamic acid in children with hemorrhagic injuries. (Acad Emerg Med, 2021)
- Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury. (J Trauma Acute Care Surg, 2020)
- Intravenous Tranexamic Acid for Subdural and Epidural Intracranial Hemorrhage: Randomized, Double-Blind, Placebo-Controlled Trial. (Rev Recent Clin Trials, 2019)